Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling akt'

Search results for: 'research area pi3k akt signaling akt'

Items 81-90 of 105

Page
per page
  1. PD 169316
    A8689 PD 169316
    Target: p38
    Summary: P38 MAPK inhibitor
      insoluble in EtOH; insoluble in H2O; ≥15.3 mg/mL
  2. Sulforaphane
    C4733 Sulforaphane
    Summary: inducer of chemopreventative enzymes via Keap1-Nrf2 signaling
      ≥51.6 mg/mL
  3. Gefitinib hydrochloride
    A3433 Gefitinib hydrochloride
    Target: EGFR
    Summary: Potent EGFR inhibitor
      insoluble in EtOH; ≥4.28 mg/mL
  4. MDV3100 (Enzalutamide)
    A3003 MDV3100 (Enzalutamide)
     12 Citation
    Target: Androgen Receptors
    Summary: Androgen receptor antagonist
      ≥23.22 mg/mL
  5. 740 Y-P
    B5246 740 Y-P
     5 Citation
    Target: PI3K
    Summary: PI 3-kinase activator,cell permeable
      ≥163.54 mg/mL
  6. AT13387
    A4056 AT13387
    Target: HSP90
    Summary: Hsp90 inhibitor
      insoluble in H2O; ≥13.25 mg/mL
  7. (R)-baclofen
    B1531 (R)-baclofen
    Target: GABAB Receptors
    Summary: GABA receptor agonist
      insoluble in DMSO; insoluble in EtOH; ≥7.13 mg/mL
  8. Semagacestat (LY450139)
    A8190 Semagacestat (LY450139)
    Summary: γ-secretase inhibitor
      insoluble in H2O; ≥18.05 mg/mL
  9. Clemizole hydrochloride
    A3316 Clemizole hydrochloride
    Target: Histamine H1 Receptors|TRPC channel
    Summary: H1 histamine receptor antagonist
  10. Necrostatin 2
    A3652 Necrostatin 2
     2 Citation
    Summary: In vitro necroptosis inhibitor
      Soluble in DMSO

Items 81-90 of 105

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 103item
  2. Natural Products 1 item
  3. Protein 2item
  4. Peptides & Proteins 3item
Specificity
  1. Selective 56item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 3item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Akt 10item
  3. PI3K 21item
  4. Raf 6item
  5. Aurora Kinases 1 item
  6. mTOR 12item
  7. Androgen Receptors 1 item
  8. FLT3 1 item
  9. GSK-3 4item
  10. VEGFR 4item
  11. PDGFR 1 item
  12. Phosphodiesterases (PDEs) 1 item
  13. p38 4item
  14. PKB 1 item
  15. MEK 3item
  16. PORCN 1 item
  17. FGFR 1 item
  18. GABAB Receptors 1 item
  19. NMDA Receptors 1 item
  20. STAT 4item
  21. EGFR 2item
  22. JAK 3item
  23. DNA-PK 3item
  24. HSP90 1 item
  25. Toll-like receptors (TLRs) 1 item
  26. ERK 2item
  27. PKC 5item
  28. ALK 1 item
  29. PKG 1 item
  30. PKA 3item
  31. RSK 1 item
  32. Histamine H1 Receptors 1 item
  33. NO Donors / Precursors 1 item
  34. IL Receptors 1 item
  35. AChE 1 item
  36. BACE 1 item
  37. p70 rsk 1 item
  38. sodium channels 1 item
  39. Smoothened receptor 1 item
  40. Nrf2/ARE signal 1 item
  41. PPAR 1 item
  42. Antibiotic 1 item
  43. Prk 1 item
  44. ICAM 1 item
  45. Rho 1 item
  46. Thrombin Receptor 1 item
  47. prolactin secretion 1 item
  48. gonadotropin release 1 item
  49. TRPC channel 1 item
  50. PKD 1 item
  51. FKBP 1 item
  52. ATM 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 2item
  3. Bladder Cancer 1 item
  4. Breast Cancer 15item
  5. Cancer 56item
  6. Cervical Cancer 1 item
  7. Colon Cancer 6item
  8. Colorectal Cancer 6item
  9. Glioblastoma 8item
  10. Glioma 4item
  11. Heart Failure 1 item
  12. Leukemia 6item
  13. Liver Cancer 1 item
  14. Lung Cancer 4item
  15. Lymphoma 2item
  16. Melanoma 5item
  17. Multiple Myeloma 1 item
  18. Myeloma 1 item
  19. Neuroblastoma 1 item
  20. Non-small Cell Lung Cancer 4item
  21. Ovarian Cancer 5item
  22. Pancreatic Cancer 6item
  23. Pancreatic Carcinoma 1 item
  24. Prostate Cancer 7item
  25. Pulmonary Fibrosis 1 item
  26. Renal Cancer 1 item
  27. Rheumatoid Arthritis 2item
  28. Thyroid Cancer 2item
  29. Type 2 Diabetes 1 item